Conferences

Conferences is a vertical on Op-Med that features overarching coverage of conferences as well as breakdowns of studies presented at conferences.

featured article image

Reducing the Numbers of Severe Exacerbations of Asthma With Biologics and Pharmacologic Treatments: PARTICS, MANDALA, SMART and More

author

Paul A Greenberger, MD

Read From AAAAI 2023: The Constantly Evolving Story of Food Allergies

Link to Manav Singla, MD's page

From AAAAI 2023: The Constantly Evolving Story of Food Allergies

Manav Singla, MD

Mar 5, 2023 Link to From AAAAI 2023: The Constantly Evolving Story of Food Allergies

Read ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advances

Link to Guru P Sonpavde, MD's page

ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advances

Guru P Sonpavde, MD

Feb 27, 2023 Link to ASCO GU 2023: Practice Changing, Practice Reaffirming, Practice Informing and Emerging Advances

Read ASCO GU 2023 Highlights With Dr. Julie Gralow

Link to Julie R Gralow, MD's page

ASCO GU 2023 Highlights With Dr. Julie Gralow

Julie R Gralow, MD

Feb 27, 2023 Link to ASCO GU 2023 Highlights With Dr. Julie Gralow

Read Imperative Paradigm Shifts at ASCO GU 2023: Health Equity, De-escalation of Surgery and the De-escalation of Manels

Link to JJ Haijing Zhang, MD's page

Imperative Paradigm Shifts at ASCO GU 2023: Health Equity, De-escalation of Surgery and the De-escalation of Manels

JJ Haijing Zhang, MD

Feb 27, 2023 Link to Imperative Paradigm Shifts at ASCO GU 2023: Health Equity, De-escalation of Surgery and the De-escalation of Manels

Read Medical Conferences Are an Opportunity To Nourish Mentorships

Link to Hardeep Singh Phull, MD's page

Medical Conferences Are an Opportunity To Nourish Mentorships

Hardeep Singh Phull, MD

Feb 6, 2023 Link to Medical Conferences Are an Opportunity To Nourish Mentorships

Read A Review of "Controversies in IBD: Shark Tank Edition"

A Review of "Controversies in IBD: Shark Tank Edition"

Alyssa Maria Parian, MD and 1 other

Jan 30, 2023 Link to A Review of "Controversies in IBD: Shark Tank Edition"

Read Milestones and New Research from ASCO GI 2023

Link to Julie R Gralow, MD's page

Milestones and New Research from ASCO GI 2023

Julie R Gralow, MD

Jan 30, 2023 Link to Milestones and New Research from ASCO GI 2023

Read Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congress

Link to James Friebe's page

Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congress

Jan 9, 2023 Link to Chatting with the Crohn's & Colitis Foundation's CEO Before the 2023 Crohn's & Colitis Congress

Read First-in-Class Agent Addresses Unmet Need in Myeloma

Link to Lynne Lederman, PhD's page

First-in-Class Agent Addresses Unmet Need in Myeloma

Lynne Lederman, PhD

Dec 19, 2022 Link to First-in-Class Agent Addresses Unmet Need in Myeloma

Read Questioning the Status Quo for Children with ALL at ASH

Link to Lynne Lederman, PhD's page

Questioning the Status Quo for Children with ALL at ASH

Lynne Lederman, PhD

Dec 19, 2022 Link to Questioning the Status Quo for Children with ALL at ASH

Read Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrence

Link to Lynne Lederman, PhD's page

Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrence

Lynne Lederman, PhD

Dec 19, 2022 Link to Pausing Endocrine Therapy to Attempt Pregnancy Does Not Increase Short-Term Breast Cancer Recurrence

Read Screening for Breast Cancer by Genetics or Imaging in Community Settings

Link to Lynne Lederman, PhD's page

Screening for Breast Cancer by Genetics or Imaging in Community Settings

Lynne Lederman, PhD

Dec 19, 2022 Link to Screening for Breast Cancer by Genetics or Imaging in Community Settings

Read How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship

Link to Hardeep Singh Phull, MD's page

How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship

Hardeep Singh Phull, MD

Dec 19, 2022 Link to How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship

Read Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Link to Stephen Douglas Smith, MD's page

Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Stephen Douglas Smith, MD

Dec 19, 2022 Link to Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Read Benefits of Virtual Conference Attendance: ASH 2022 Edition

Link to Samuel Kareff, MD MPH's page

Benefits of Virtual Conference Attendance: ASH 2022 Edition

Samuel Kareff, MD MPH

Dec 19, 2022 Link to Benefits of Virtual Conference Attendance: ASH 2022 Edition

Read Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Link to Hayder Saeed, MD's page

Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Hayder Saeed, MD

Dec 19, 2022 Link to Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Read Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Link to Suzanne Baga, MA, RRT's page

Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Suzanne Baga, MA, RRT

Dec 19, 2022 Link to Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Read Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Heather Moore, CPP, PharmD and 1 other

Dec 19, 2022 Link to Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Read Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Link to Kimberly J. Van Zee, MS, MD, FACS's page

Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Kimberly J. Van Zee, MS, MD, FACS

Dec 18, 2022 Link to Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Read Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Link to Katharine Yao, MD's page

Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Katharine Yao, MD

Dec 18, 2022 Link to Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Read HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Link to Kalliopi Siziopikou, MD PhD's page

HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Kalliopi Siziopikou, MD PhD

Dec 18, 2022 Link to HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing